Women's Health Diagnostics Market by Application End User - Forecast to 2021

News provided by

Nov 29, 2016, 07:56 ET

NEW YORK, Nov. 29, 2016 /PRNewswire/ --

The global women's health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market. Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.

In this report, the global women health diagnostics market is segmented on the basis of application and end user. On the basis of application, the market is segmented into nine segments namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. The osteoporosis segment is further divided into bone densitometry and in vitro blood tests. The ovarian cancer segment is divided into tumor marker tests, diagnostic imaging tests and others. The cervical cancer segment is sub segmented into PAP smear testing and HPV testing. The breast cancer testing segment is further divided into mammography, tumor marker tests, blood cell count & blood chemistries, biopsies and other diagnostic imaging tests. Pregnancy and fertility testing market is sub segmented into lab-based testing, pregnancy self-test and ovulation prediction kits, ovulation prediction kits, fertility monitors and thermometers. The prenatal genetic screening & carrier testing segment is further divided into cystic fibrosis, Down syndrome and Edward syndrome, TORCH infections and others (fragile x-syndrome & tay-sachs diseases). Further on, the infectious disease testing market segment is sub segmented into methicillin-resistant staphylococcus aurea (MRSA), urinary tract infections (vaginal pH & vaginitis), hepatitis, tuberculosis, and others infectious disease testing. The sexually transmitted disease testing segment comprises Chlamydia Trachomatis and Neisseria Gonorrohoeae testing, HIV testing and other STD testing.. The ultrasound segment covers breast imaging and ob/gyn imaging. On the basis of end user, the women's health diagnostics market is segmented into hospitals & clinics, home care, and diagnostic & imaging centers.

Geographically, the global women's health diagnostics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded the largest share of the global women health diagnostics market. The major share of this region can be attributed to increasing prevalence of cancer among women in this region, increasing incidence of lifestyle related health disorders, growing focus of manufacturers of women's health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors.

The prominent players in this market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

Target Audience:

Hospitals and Clinics
Medical Research and Development (R&D) Companies
Medical Device Companies
Women Health Diagnostics Solutions' Vendors
Medical Device Manufacturers
Imaging and Diagnostic Centers
Market Research and Consulting Firms
Venture Capitalists and Investors
To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

The research report categorizes the women's health diagnostics market into the following segments and subsegments:

Global women's health diagnostics market, by application

Breast Cancer Testing
Mammography Systems
Breast Cancer Tumor Marker Tests
Blood Chemistries and Blood Cell Count
Biopsies
Other Diagnostic Imaging Tests
Infectious Disease Testing
Urinary Tract Infection Testing
MRSA Testing
Hepatitis Testing
Tuberculosis Testing
Other Infectious Disease Testing
Cervical Cancer Testing
Pap Smear
HPV Testing
Osteoporosis Testing
Bone Densitometry
In Vitro Blood Tests
Sexually Transmitted Disease Testing
Chlamydia Trachomatis And Neisseria Gonorrhoeae (Ct/Ng) Testing
HIV Testing
Other Sexually Transmitted Diseases
Prenatal Genetic Screening and Carrier Testing
Cystic Fibrosis
Down Syndrome and Edward Syndrome
TORCH Infections
Other Diseases
Ultrasound
OB/GYN Imaging
Breast Imaging
Pregnancy and Fertility Testing
Pregnancy Testing and Ovulation Prediction Kits
Lab-based Testing
Fertility Monitors
Ovarian Cancer Testing
Ovarian Cancer Tumor Marker Tests
Diagnostic Imaging Tests
Other Tests

Global women health diagnostics market, by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific (RoAPAC)
RoW
Latin America
Middle East & Africa
Read the full report: http://www.reportlinker.com/p04402606-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001